Quick Comparison
| Noopept | Vitamin D3 | |
|---|---|---|
| Half-Life | 30-60 minutes (active metabolite cycloprolylglycine persists longer) | 15-25 days |
| Typical Dosage | Standard: 10-30 mg sublingually or orally, 2-3 times daily. Sublingual administration provides faster onset. Do not exceed 30 mg per dose. | Standard: 2000-5000 IU daily. Optimal blood level: 40-60 ng/mL (100-150 nmol/L). Most adults need 4000-5000 IU to reach optimal levels. Take with fat for absorption. Get blood levels tested before supplementing — both deficiency and excess are harmful. |
| Administration | Oral or sublingual (sublingual preferred for faster onset and higher bioavailability). Available as powder, capsules, or sublingual tablets. | Oral (softgels, drops, tablets). D3 (cholecalciferol) preferred over D2 (ergocalciferol). Take with a fat-containing meal. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
Noopept
Noopept modulates AMPA and NMDA receptors similarly to racetams through positive allosteric modulation. Its key distinguishing feature is upregulation of BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) via activation of TrkB and TrkA receptor signaling cascades — these neurotrophins are essential for neuronal growth, survival, dendritic arborization, and synaptic plasticity. Noopept inhibits glutamate-induced excitotoxicity by reducing calcium influx through NMDA receptors and modulating the NR2B subunit. It activates the PI3K/Akt and MAPK/ERK pathways downstream of neurotrophin receptors. The active metabolite cycloprolylglycine (a cyclic dipeptide) has endogenous nootropic activity, potentially acting as a trace amine-associated receptor ligand. Neuroprotection is further mediated through antioxidant effects and mitochondrial stabilization.
Vitamin D3
Vitamin D (1,25-dihydroxyvitamin D3) crosses the blood-brain barrier and binds to vitamin D receptors (VDR), a nuclear receptor expressed on neurons, astrocytes, microglia, and oligodendrocytes. VDR heterodimerizes with RXR and binds vitamin D response elements (VDREs) to regulate transcription. It upregulates neurotrophic factors: GDNF (glial cell line-derived), NGF, NT-3 via CREB and other transcription factors. Vitamin D promotes serotonin synthesis by upregulating tryptophan hydroxylase 2 (TPH2) and dopamine synthesis via tyrosine hydroxylase. It reduces neuroinflammation by suppressing microglial IL-1beta, TNF-alpha, and iNOS, and supports calcium homeostasis via regulation of L-type voltage-gated calcium channels and calbindin-D28k. Vitamin D regulates over 200 genes including those for neuroprotection, synaptic plasticity, and myelination.
Risks & Safety
Noopept
Common
Headache (especially without choline supplementation), irritability at higher doses, brain fog in some users.
Serious
No serious adverse effects documented.
Rare
Emotional blunting at high doses, insomnia, allergic reactions.
Vitamin D3
Common
Generally very safe at standard doses.
Serious
Toxicity at very high doses (>10,000 IU daily for months) — causes hypercalcemia (nausea, kidney stones, cardiac arrhythmia).
Rare
Headache, metallic taste, nausea.
Full Profiles
Noopept →
A synthetic peptide-derived nootropic often grouped with racetams due to similar effects, though it is technically a dipeptide analog of piracetam. Roughly 1000x more potent by weight than piracetam, requiring only 10-30 mg per dose. It provides both immediate cognitive enhancement and long-term neuroprotective benefits through BDNF and NGF upregulation.
Vitamin D3 →
Technically a hormone, not a vitamin. Vitamin D3 (cholecalciferol) receptors are found throughout the brain, particularly in the hippocampus and prefrontal cortex. Deficiency — affecting an estimated 40-75% of adults worldwide — is associated with cognitive impairment, depression, and increased Alzheimer's risk. Supplementation is one of the most impactful interventions for people with low levels.